arGEN-X continues to raise funds as SIMPLE antibody platform gathers pace
This article was originally published in Scrip
Executive Summary
arGEN-X, a therapeutic antibody discovery company, has received a €1.5 million grant from the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT).